DESIGN, SYNTHESIS AND BIOLOGICAL EVALUATION OF NOVEL HETEROCYCLIC COMPOUNDS AS POTENTIAL ANTIMICROBIAL AGENTS
Keywords:
heterocyclic compounds; benzimidazole; thiazole; antimicrobial agents; drug design; structure-activity relationship; MIC; drug-likenessAbstract
Antimicrobial resistance continues to reduce the effectiveness of established antibacterial agents and has intensified the search for structurally novel small molecules. Heterocyclic frameworks, particularly nitrogen- and sulfur-containing rings, remain central to medicinal chemistry because they permit dense functionalization, directional hydrogen bonding, aromatic stacking and tunable lipophilicity. This study presents a literature-grounded pre-experimental design of eight benzimidazole-thiazole hybrids (H1-H8) as candidate antimicrobial agents. The compounds were constructed around a 2-(benzimidazol-2-yl)-4-arylthiazole core and diversified by para-substitution of the phenyl ring with H, F, Cl, Br, CH3, OCH3, CF3 and NO2 groups. A Hantzsch-type thiazole formation from benzimidazole-2-carbothioamide and substituted alpha-bromoacetophenones is proposed as the synthetic route. Physicochemical descriptors were calculated from the explicit molecular structures using RDKit, and drug-likeness was interpreted using the Rule-of-Five concept and the quantitative estimate of drug-likeness (QED). The designed series had molecular weights of 277.35-356.25 g/mol, TPSA values of 41.6-84.7 A2 and QED scores of 0.451-0.611. H6 (OCH3) provided the most balanced QED profile, while H3, H4 and H7 crossed or approached the cLogP=5 boundary, indicating a potential solubility risk. A standardized broth microdilution protocol compliant with CLSI/EUCAST principles is proposed for subsequent MIC and MBC determination against representative Gram-positive and Gram-negative bacteria. The work establishes a transparent design-to-validation framework without presenting unperformed laboratory assays as experimental results.
References
1. World Health Organization. (2024). WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: WHO. ISBN 978-92-4-009346-1.
2. Clinical and Laboratory Standards Institute. (2024). M07: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically (12th ed.). Wayne, PA: CLSI.
3. European Committee on Antimicrobial Susceptibility Testing. (2024). MIC determination of non-fastidious and fastidious organisms: Broth microdilution methodology and reading guidance. EUCAST.
4. Cebeci, Y. U., Batur, O. O., & Boulebd, H. (2024). Design, synthesis, theoretical studies, and biological activity evaluation of new nitrogen-containing poly heterocyclic compounds as promising antimicrobial agents. Journal of Molecular Structure, 1299, 137115. https://doi.org/10.1016/j.molstruc.2023.137115
5. Patel, M., Avashthi, G., Gacem, A., Alqahtani, M. S., Park, H.-K., & Jeon, B.-H. (2023). A review of approaches to the metallic and non-metallic synthesis of benzimidazole (BnZ) and their derivatives for biological efficacy. Molecules, 28(14), 5490. https://doi.org/10.3390/molecules28145490
6. Alzhrani, Z. M. M., Alam, M. M., & Nazreen, S. (2022). Recent advancements on benzimidazole: A versatile scaffold in medicinal chemistry. Mini-Reviews in Medicinal Chemistry, 22(2), 365-386. https://doi.org/10.2174/1389557521666210331163810
7. Tian, G., Song, Q., Liu, Z., Guo, J., Cao, S., & Long, S. (2023). Recent advances in 1,2,3- and 1,2,4-triazole hybrids as antimicrobials and their SAR: A critical review. European Journal of Medicinal Chemistry, 259, 115603. https://doi.org/10.1016/j.ejmech.2023.115603
8. Guo, J., Xie, Z., Ruan, W., Tang, Q., Qiao, D., & Zhu, W. (2023). Thiazole-based analogues as potential antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA) and their SAR elucidation. European Journal of Medicinal Chemistry, 259, 115689. https://doi.org/10.1016/j.ejmech.2023.115689
9. Khamitova, A., Berillo, D., Lozynskyi, A., Konechnyi, Y., Mural, D., Georgiyants, V., & Lesyk, R. (2024). Thiadiazole and thiazole derivatives as potential antimicrobial agents. Mini-Reviews in Medicinal Chemistry, 24(5), 531-545. https://doi.org/10.2174/1389557523666230713115947
10. Rehman, M. U., He, F., Shu, X., Guo, J., Liu, Z., Cao, S., & Long, S. (2025). Antibacterial and antifungal pyrazoles based on different construction strategies. European Journal of Medicinal Chemistry, 282, 117081. https://doi.org/10.1016/j.ejmech.2024.117081
11. Marinescu, M. (2023). Benzimidazole-triazole hybrids as antimicrobial and antiviral agents: A systematic review. Antibiotics, 12(7), 1220. https://doi.org/10.3390/antibiotics12071220
12. Niu, Z.-X., Wang, Y.-T., Zhang, S.-N., Li, Y., Chen, X.-B., Wang, S.-Q., & Liu, H.-M. (2023). Application and synthesis of thiazole ring in clinically approved drugs. European Journal of Medicinal Chemistry, 250, 115172. https://doi.org/10.1016/j.ejmech.2023.115172
13. Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 46(1-3), 3-26. https://doi.org/10.1016/S0169-409X(00)00129-0
14. Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
15. Bickerton, G. R., Paolini, G. V., Besnard, J., Muresan, S., & Hopkins, A. L. (2012). Quantifying the chemical beauty of drugs. Nature Chemistry, 4(2), 90-98. https://doi.org/10.1038/nchem.1243
